세계의 혈액제제 시장 보고서(2025년)
Blood Preparation Global Market Report 2025
상품코드 : 1821718
리서치사 : The Business Research Company
발행일 : On Demand Report
페이지 정보 : 영문 250 Pages
 라이선스 & 가격 (부가세 별도)
US $ 4,490 ₩ 6,516,000
PDF (Single User License) help
PDF 보고서를 1명만 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 6,490 ₩ 9,419,000
PDF (Site License) help
PDF 보고서를 동일 사업장의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.
US $ 8,490 ₩ 12,322,000
PDF (Enterprise License) help
PDF 보고서를 동일 기업의 모든 분이 이용할 수 있는 라이선스입니다. 인쇄 가능하며 인쇄물의 이용 범위는 PDF 이용 범위와 동일합니다.


ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.

한글목차

혈액제제 시장 규모는 향후 수년간 강력한 성장이 예상됩니다. 2029년에 CAGR(연평균 성장률) 6.7%를 나타낼 것으로 예측되고 662억 9,000만 달러로 성장할 전망입니다. 예측 기간 동안의 성장은 혈액 컴포넌트에 대한 수요 증가, 맞춤형 의약품 접근법, 신흥 치료법 및 용도, 전 세계 의료 인프라 개발 등에 기인할 수 있습니다. 예측 기간의 주요 동향에는 혈액 처리 시스템의 자동화 및 통합, 병원체 감축된 혈액 컴포넌트 수요 증가, 혈액 컴포넌트의 맞춤화 및 개인화, 혈소판 풍부 플라즈마(PRP) 및 혈소판 풍부 피브린(PRF)을 주력하는 점, 규제 준수 및 엄격한 품질 기준 등이 포함됩니다.

향후 5년간 6.7% 성장 전망은 이전 예측 대비 0.1% 소폭 하향 조정된 수치입니다. 이 같은 하향 조정은 주로 미국과 타국 간 관세 부과 영향 때문입니다. 관세 부과로 인해 이탈리아 및 벨기에에서 수입되는 자동 세포 분리기 및 백혈구 필터의 접근성이 제한될 수 있어, 미국 혈액 서비스 업계에 상당한 도전 과제가 될 전망입니다. 이는 혈액 컴포넌트 품질 감축 및 처리 비용 증가로 이어질 수 있습니다. 또한 상호 보복 관세와 무역 긴장 및 제한 강화로 인한 세계 경제 및 무역에 대한 부정적 영향으로 그 영향이 더욱 광범위하게 나타날 것입니다.

전 세계적으로 증가하는 헌혈은 혈액제제 시장을 촉진할 것으로 예상됩니다. 헌혈은 의료용 혈액을 기증하는 이타적 행위로, 수술, 암 치료, 만성 질환 및 외상 치료에 필수적인 수혈을 통해 생명을 유지합니다. 이 과정은 준비 과정에서 언제 어디서든 필요한 혈액의 공급을 보장합니다. 예를 들어, 국립 혈액 서비스 가나는 2020년 156,453단위에서 2021년 173,938단위로 채혈량 증가를 보고했습니다. 또한 세계은행의 데이터에 따르면 2020년 6월부터 2021년 6월에 걸친 채혈량은 86% 급증하여 186,239단위에 이르며 21만 4,187명 이상에 대응했습니다. 따라서 헌혈 증가는 혈액제제 시장의 성장을 가속합니다.

목차

제1장 주요 요약

제2장 시장 특징

제3장 시장 동향과 전략

제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁과 관세, 그리고 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오

제5장 세계의 성장 분석과 전략 분석 프레임워크

제6장 시장 세분화

제7장 지역별 및 국가별 분석

제8장 아시아태평양 시장

제9장 중국 시장

제10장 인도 시장

제11장 일본 시장

제12장 호주 시장

제13장 인도네시아 시장

제14장 한국 시장

제15장 서유럽 시장

제16장 영국 시장

제17장 독일 시장

제18장 프랑스 시장

제19장 이탈리아 시장

제20장 스페인 시장

제21장 동유럽 시장

제22장 러시아 시장

제23장 북미 시장

제24장 미국 시장

제25장 캐나다 시장

제26장 남미 시장

제27장 브라질 시장

제28장 중동 시장

제29장 아프리카 시장

제30장 경쟁 구도와 기업 프로파일

제31장 기타 주요 기업 및 혁신 기업

제32장 세계 시장 경쟁 벤치마킹과 대시보드

제33장 주요 인수합병(M&A)

제34장 최근 시장 동향

제35장 시장의 잠재력이 높은 국가, 부문, 전략

제36장 부록

HBR
영문 목차

영문목차

Blood preparation encompasses the comprehensive process of gathering, processing, and preserving blood and its components for utilization in transfusions or various medical treatments. This intricate procedure involves several stages such as donor screening, blood collection, testing, storage, and eventual transfusion.

The primary categories of blood preparation products include whole blood, blood components, and blood derivatives. Whole blood signifies blood that hasn't been separated into its individual constituents such as red blood cells, white blood cells, and plasma. It contains various antithrombotic and anticoagulant elements, including platelet aggregation inhibitors, fibrinolytics, and anticoagulants, which find applications in transfusions, diagnostics, and research purposes. Key end-users of these blood preparation products encompass hospitals, clinics, blood banks, and other medical facilities involved in managing and administering transfusions and medical treatments requiring blood and its components.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.

The blood preparation market research report is one of a series of new reports from The Business Research Company that provides blood preparation market statistics, including blood preparation industry global market size, regional shares, competitors with a blood preparation market share, detailed blood preparation market segments, market trends and opportunities, and any further data you may need to thrive in the blood preparation industry. This blood preparation market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The blood preparation market size has grown strongly in recent years. It will grow from $48.03 billion in 2024 to $51.13 billion in 2025 at a compound annual growth rate (CAGR) of 6.4%. The growth in the historic period can be attributed to rise in blood transfusion procedures, increasing prevalence of blood disorders, growing awareness of blood safety, global initiatives for blood donation, government regulations and standards.

The blood preparation market size is expected to see strong growth in the next few years. It will grow to $66.29 billion in 2029 at a compound annual growth rate (CAGR) of 6.7%. The growth in the forecast period can be attributed to rising demand for blood components, personalized medicine approaches, emerging therapies and applications, global healthcare infrastructure development. Major trends in the forecast period include automation and integration of blood processing systems, demand for pathogen-reduced blood components, customization and personalization in blood components, focus on platelet-rich plasma (PRP) and platelet-rich fibrin (PRF), regulatory compliance and stringent quality standards.

The forecast of 6.7% growth over the next five years reflects a slight reduction of 0.1% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. The imposition of tariffs may pose a significant challenge for U.S. blood services by restricting access to automated cell separators and leukocyte filters imported from Italy and Belgium, potentially reducing blood component quality and increasing processing costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.

The increasing global blood donations are set to drive the growth of the blood preparation market. Blood donation involves the altruistic act of contributing blood for medical use, sustaining life through transfusions crucial in surgeries, cancer treatment, chronic illnesses, and trauma care. This process ensures the availability of blood whenever and wherever needed during preparation. For example, National Blood Service Ghana reported a rise in blood collections, from 156,453 units in 2020 to 173,938 units in 2021. Additionally, World Bank data indicated an 86% surge in blood collections from June 2020 to June 2021, reaching 186,239 units, catering to over 214,187 individuals. Therefore, the increase in blood donations propels the blood preparation market's growth.

The rise in blood-related disorders is anticipated to boost the blood preparation market. These disorders encompass diverse conditions such as blood cancers that impact blood components, functions, or clotting abilities, often necessitating transfusions or specialized treatments. Instances of deficiencies in clotting factors, red blood cells, or platelets drive the need for blood preparation. For instance, Blood Cancer UK revealed that around 41,000 individuals receive blood cancer diagnoses annually in the UK, with approximately 250,000 currently living with this condition. Statistics indicate a one in 16 men and one in 22 women likelihood of developing blood cancer during their lifetime. Hence, the increasing prevalence of blood-related disorders fuels the blood preparation market's growth.

Technological advancements are emerging as a significant trend in the blood preparation market. Leading companies in this sector are concentrating on developing innovative technological solutions to maintain their competitive edge. For instance, in June 2024, Innobiochips, a biotechnology company based in France, launched Omnys, an advanced blood grouping and testing solution designed to enhance the efficiency and precision of blood transfusion processes. Utilizing patented multiplex technologies, Omnys allows for high-resolution testing of various blood components, including ABO/D typing, phenotyping, extended phenotyping, and antibody screening. This all-in-one system integrates testing devices, reagents, and consumables to optimize workflows, enabling healthcare facilities and laboratories to conduct accurate blood analyses with minimal sample volumes.

Major players in the blood preparation market focus on product innovation, exemplified by advanced blood sampling kits, to improve accuracy and efficiency in blood collection processes. These kits streamline and enhance blood sample collection for diagnostic purposes. Capitainer, in December 2022, launched an upgraded self-sampling blood card collecting a larger volume (2 x 50 microliters), facilitating the measurement of additional biomarkers and enabling a broader range of analyses due to the increased blood quantity for accurate testing of specific substances. This innovation significantly enhances accuracy and ease in blood collection processes.

In October 2022, Pfizer Inc., a pharmaceutical and biotechnology company based in the U.S., acquired Global Blood Therapeutics for $5.4 billion. This acquisition aims to strengthen Pfizer's portfolio in treating sickle cell disease and to meet the critical needs of an underserved patient population. Global Blood Therapeutics Inc. is a U.S.-based biopharmaceutical company that primarily focuses on developing therapies for blood-related disorders, with a particular emphasis on sickle cell disease.

Major companies operating in the blood preparation market include AstraZeneca PLC, Sanofi, LEO Pharma A/S, Bristol-Myers Squibb Company, Baxter International Inc, Pfizer Inc, Portola Pharmaceuticals Inc, GlaxoSmithKline PLC, Bayer AG, Boehringer Ingelheim, Celgene Corp, Shandong East Chemical Industry Co., Xiamen Hisunny Chemical Co. LTD, Merck & Co., Amgen Inc., Takeda Pharmaceutical Company Limited, Novartis AG, Johnson & Johnson, Gilead Sciences Inc., Regeneron Pharmaceuticals Inc., AbbVie Inc., Roche Holding AG, CSL Behring, BioMarin Pharmaceutical Inc., Genentech Inc., Sandoz International GmbH, Medtronic plc, Fresenius Kabi AG, Grifols S.A., HemaCare Corporation, Terumo Corporation

North America was the largest region in the blood preparation market in 2024. Asia-Pacific is expected to be the fastest-growing region in the global blood preparation market during the forecast period. The regions covered in the blood preparation market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the blood preparation market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain

The blood preparation market consists of revenues earned by entities by providing services such as blood processing, blood storing, and distributing blood and blood components for transfusion services. The market value includes the value of related goods sold by the service provider or included within the service offering. The blood preparation market also includes sales of red cells, platelets, cryoprecipitated AHF (CRYO), and granulocytes, which are used in providing blood preparation services. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Blood Preparation Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on blood preparation market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

Where is the largest and fastest growing market for blood preparation ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The blood preparation market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

Scope

Table of Contents

1. Executive Summary

2. Blood Preparation Market Characteristics

3. Blood Preparation Market Trends And Strategies

4. Blood Preparation Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

5. Global Blood Preparation Growth Analysis And Strategic Analysis Framework

6. Blood Preparation Market Segmentation

7. Blood Preparation Market Regional And Country Analysis

8. Asia-Pacific Blood Preparation Market

9. China Blood Preparation Market

10. India Blood Preparation Market

11. Japan Blood Preparation Market

12. Australia Blood Preparation Market

13. Indonesia Blood Preparation Market

14. South Korea Blood Preparation Market

15. Western Europe Blood Preparation Market

16. UK Blood Preparation Market

17. Germany Blood Preparation Market

18. France Blood Preparation Market

19. Italy Blood Preparation Market

20. Spain Blood Preparation Market

21. Eastern Europe Blood Preparation Market

22. Russia Blood Preparation Market

23. North America Blood Preparation Market

24. USA Blood Preparation Market

25. Canada Blood Preparation Market

26. South America Blood Preparation Market

27. Brazil Blood Preparation Market

28. Middle East Blood Preparation Market

29. Africa Blood Preparation Market

30. Blood Preparation Market Competitive Landscape And Company Profiles

31. Blood Preparation Market Other Major And Innovative Companies

32. Global Blood Preparation Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Blood Preparation Market

34. Recent Developments In The Blood Preparation Market

35. Blood Preparation Market High Potential Countries, Segments and Strategies

36. Appendix

(주)글로벌인포메이션 02-2025-2992 kr-info@giikorea.co.kr
ⓒ Copyright Global Information, Inc. All rights reserved.
PC버전 보기